Around 31.3 million shares, or nearly 20% of the company’s total outstanding equity, will become eligible for trading, according to Nuvama Alternative and Quantitative Research.
Around 31.3 million shares, or nearly 20% of the company’s total outstanding equity, will become eligible for trading, according to Nuvama Alternative and Quantitative Research.